Iodine Brachytherapy as an Alternative to Enucleation for Large Uveal Melanomas

Ophthalmology

Volumn 110, Issue 11, 2003, Pages 2223-2234

  Puusaari, Ilkka ^a   Heikkonen, Jorma ^a   Summanen, Paula ^a   Tarkkanen, Ahti ^a   Kivelä, Tero ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; IODINE 125; RUTHENIUM;

ADULT; AGED; ARTICLE; B SCAN; BIOMICROSCOPY; BLINDNESS; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENUCLEATION; EYE TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; PRIORITY JOURNAL; TREATMENT OUTCOME; UVEA TUMOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0242380826     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(03)00661-4     Document Type: Article

References (39)

1. The Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9. Am J Ophthalmol 1998:125:767-78.
2. Shields JA. Management of posterior uveal melanoma: past, present, future. Retina 2002;22:139-42.
3. De Potter P. Approches thérapeutiques actuelles du melanome de la choroïde [Choroidal melanoma: current therapeutic approaches]. J Fr Ophtalmol 2002;25:203-11.
4. Damato BE. An approach to the management of patients with uveal melanoma. Eye 1993;7:388-97.
5. Shields JA, Shields CL, De Potter P, et al. Plaque radiotherapy for uveal melanoma. Int Ophthalmol Clin 1993;33:129-35.
6. Fuss M, Loredo LN, Blacharski PA, et al. Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 2001;49:1053-9.
7. Egger E, Schalenbourg A, Zografos L, et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys 2001;51:138-47.
8. Tokuuye K, Akine Y, Sumi M, et al. Fractionated stereotactic radiotherapy for choroidal melanoma. Radiother Oncol 1997;43:87-91.
9. Haas A, Pinter O, Papaefthymiou G, et al. Incidence of radiation retinopathy after high-dosage single-fraction gamma knife radiosurgery for choroidal melanoma. Ophthalmology 2002;109:909-13.
10. Shields CL, Shields JA, Cater J, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000;118:1219-28.
11. Damato BE, Foulds WS. Surgical resection of choroidal melanoma. In: Ryan SJ, Ogden TE, Hinton DR, et al, eds. Retina, 3rd ed. St. Louis: Mosby Inc.; 2001:762-72.
12. Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996;41:215-28.
13. Eskelin S, Pyrhönen S, Summanen P, et al. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000;107:1443-9.
14. Singh AD. Uveal melanoma: implications of tumor doubling time [letter]. Ophthalmology 2000;108:829-31.
15. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119:969-82.
16. The Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998;125:779-96.
17. Melia BM, Abramson DH, Albert DM, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of 1-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no. 16. Ophthalmology 2001;108:348-66.
18. De Potter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol 1996;114:1357-65.
19. Packer S, Stoller S, Lesser ML, et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992;99:767-73.
20. 125 I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1993;26:613-8.
21. Heikkonen J, Summanen P, Immonen I, et al. Radiotherapy of malignant melanoma of the uvea with I-125 seeds. Acta Ophthalmol (Copenh) 1992;70:780-5.
22. 125I seeds. Med Phys 1985;12:652-5.
23. 125I seed eye plaques. Med Phys 1986;13:78-83.
24. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995;22:209-34.
25. Harbour JW, Char DH, Kroll S, et al. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 1997;104:1785-92.
26. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol 2001;119:670-6.
27. Hosmer DW Jr, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York: John Wiley & Sons; 1999.
28. Cleves M. Analysis of Multiple Failure-time Data with Stata. Stata Technical Bulletin 1999;49.
29. Therneau TM, Grambsch PM. Modeling Survival Data: Extending the Cox Model. New York: Springer, 2000.
30. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989:84:1074-8.
31. Parmar MKB, Machin D. Survival Analysis. A Practical Approach. Chichester: John Wiley & Sons; 1996.
32. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983:101:1894-9.
33. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 1977;95:63-9.
34. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control. Cancer 1996;77:2356-62.
35. Sia S, Harper C, McAllister I, Perry A. Iodine-125 episcleral plaque therapy in uveal melanoma. Clin Experiment Ophthalmol 2000;28:409-13.
36. 125I ophthalmic plaque brachytherapy. Med Phys 1990;17:1053-7.
37. Vrabec TR, Augsburger JJ, Gamel JW, et al. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991;98:984-8.
38. Damato B. Disease and "dis-ease" in patients with uveal melanoma. Br J Ophthalmol 2000;84:343-4.
39. Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol 2000;118:1066-70.